Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

S 9172Session 2025-2026

Relates to direct access laboratory testing for certain lipid screening assays

S9172

Underlined text would be added to current law. Struck-through text would be removed.

Skip to main content

New York State Assembly

Speaker Carl E. Heastie

  • Assembly Members
  • Legislative Info
  • Public Hearings
  • Speaker's Press
  • Assembly Reports
  • Committees & More
  • Bill Search Home
  • Laws
  • Legislative Calendar
  • Public Hearing Schedule
  • Assembly Calendars
  • Assembly Committee Agenda
Javascript must be enabled to properly view this page. Bill No.:  
     
  •  Summary 
  •  
  •  Actions 
  •  
  •  Committee&nbspVotes 
  •  
  •  Floor&nbspVotes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber&nbspVideo/Transcript 

S09172 Summary:

BILL NOS09172
 
SAME ASNo Same As
 
SPONSORFAHY
 
COSPNSR
 
MLTSPNSR
 
Add ?579-a, Pub Health L
 
Provides that clinical laboratories may provide laboratory testing at the request of individuals, without a practitioner order or prescription, for certain types of cholesterol.
Go to top

S09172 Text:

STATE OF NEW YORK ________________________________________________________________________ 9172 IN SENATE February 10, 2026 ___________ Introduced by Sen. FAHY -- read twice and ordered printed, and when printed to be committed to the Committee on Health AN ACT to amend the public health law, in relation to direct access laboratory testing for certain lipid screening assays The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. The public health law is amended by adding a new section 2 579-a to read as follows: 3 § 579-a. Direct access laboratory testing for certain lipid screening 4 assays. 1. Authorization. Notwithstanding any other provision of law, a 5 clinical laboratory licensed pursuant to this article may perform labo- 6 ratory testing, at the request of an individual and without a practi- 7 tioner order or prescription, limited to the following assays: low-den- 8 sity lipoprotein cholesterol (LDL-C), including direct measurement or 9 calculated HDL cholesterol, LDL cholesterol, triglycerides, total 10 cholesterol, and lipoprotein(a) (Lp(a)). 11 2. Laboratory requirements. A clinical laboratory performing testing 12 pursuant to this section shall: 13 (a) provide the test results to the subject of the test in a clear and 14 understandable format; and 15 (b) comply with all applicable requirements of this article, regu- 16 lations promulgated thereunder, and the federal clinical laboratory 17 improvement amendments of 1988 (CLIA). 18 3. Limitations. Nothing in this section shall be construed to: 19 (a) authorize the diagnosis or treatment of any disease or condition 20 by a clinical laboratory; 21 (b) expand or alter the scope of practice of any licensed health care 22 profession; or 23 (c) permit direct access laboratory testing without a practitioner 24 order for any assay other than those expressly identified under subdivi- 25 sion one of this section. 26 § 2. This act shall take effect on the one hundred eightieth day after 27 it shall have become a law. Effective immediately, the commissioner of 28 health is authorized to take any actions necessary to implement this act 29 on or before such effective date. EXPLANATION--Matter in italics (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD14382-02-6 Go to top <link href="/styles/noscript_styles.css" rel="stylesheet"/> Sitemap Request Information Directions and Maps

Official text from the New York Legislature. Formatting has been adapted for reading on Ratifi.